Russell Investments Group’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-43,598
| Closed | -$37.5K | – | 3385 |
|
|
2023
Q4 | $37.5K | Sell |
43,598
-80,530
| -65% | -$69.2K | ﹤0.01% | 2666 |
|
|
2023
Q3 | $133K | Buy |
124,128
+10,933
| +10% | +$11.7K | ﹤0.01% | 2573 |
|
|
2023
Q2 | $293K | Buy |
113,195
+68,551
| +154% | +$178K | ﹤0.01% | 2385 |
|
|
2023
Q1 | $182K | Sell |
44,644
-1,042
| -2% | -$4.25K | ﹤0.01% | 2494 |
|
|
2022
Q4 | $229K | Buy |
45,686
+21,354
| +88% | +$107K | ﹤0.01% | 2540 |
|
|
2022
Q3 | $317K | Buy |
24,332
+11,832
| +95% | +$154K | ﹤0.01% | 2408 |
|
|
2022
Q2 | $160K | Sell |
12,500
-3,683
| -23% | -$47.1K | ﹤0.01% | 2582 |
|
|
2022
Q1 | $246K | Sell |
16,183
-4,442
| -22% | -$67.5K | ﹤0.01% | 2422 |
|
|
2021
Q4 | $364K | Sell |
20,625
-6,755
| -25% | -$119K | ﹤0.01% | 2542 |
|
|
2021
Q3 | $574K | Buy |
27,380
+7,320
| +36% | +$153K | ﹤0.01% | 2406 |
|
|
2021
Q2 | $393K | Sell |
20,060
-1,762
| -8% | -$34.5K | ﹤0.01% | 2692 |
|
|
2021
Q1 | $633K | Sell |
21,822
-12,140
| -36% | -$352K | ﹤0.01% | 2427 |
|
|
2020
Q4 | $1.03M | Sell |
33,962
-1,689
| -5% | -$51.1K | ﹤0.01% | 2106 |
|
|
2020
Q3 | $566K | Sell |
35,651
-5,373
| -13% | -$85.3K | ﹤0.01% | 2336 |
|
|
2020
Q2 | $807K | Buy |
41,024
+8,902
| +28% | +$175K | ﹤0.01% | 2169 |
|
|
2020
Q1 | $396K | Buy |
+32,122
| New | +$396K | ﹤0.01% | 2278 |
|